Cargando…

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination

Many safe and effective severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccinations dramatically reduce risks of coronavirus disease 2019 (COVID‐19) complications and deaths. We aimed to describe cases of SARS‐CoV‐2 infection among patients with chronic liver disease (CLD) and liver tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Andrew M., Webb, Gwilym J., García‐Juárez, Ignacio, Kulkarni, Anand V., Adali, Gupse, Wong, David K., Lusina, Beth, Dalekos, George N., Masson, Steven, Shore, Brandon M., Barnes, Eleanor, Barritt, A. Sidney, Marjot, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652790/ https://www.ncbi.nlm.nih.gov/pubmed/34708575 http://dx.doi.org/10.1002/hep4.1853

Ejemplares similares

Determining risk factors for mortality in liver transplant patients with COVID-19
por: Webb, Gwilym J, et al.
Publicado: (2020)

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients
por: Webb, Gwilym J., et al.
Publicado: (2021)

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
por: Baldelli, Luke, et al.
Publicado: (2023)

COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021)

COVID-19 and liver disease: mechanistic and clinical perspectives
por: Marjot, Thomas, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
por: Marjot, Thomas, et al.
Publicado: (2021)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
por: Webb, Gwilym J, et al.
Publicado: (2020)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study
por: Adali, Gupse, et al.
Publicado: (2023)

SARS-CoV-2 infection in patients with autoimmune hepatitis
por: Marjot, Thomas, et al.
Publicado: (2021)

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard
por: Moon, Andrew M., et al.
Publicado: (2020)

Portal vein thrombosis risk factors in liver transplant candidates
por: Ak, Cagatay, et al.
Publicado: (2022)

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
por: Wang, Tingyan, et al.
Publicado: (2021)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
por: Marjot, Thomas, et al.
Publicado: (2021)

Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls
por: Serrano Rodriguez, Pablo, et al.
Publicado: (2018)

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
por: Colak, Yasar, et al.
Publicado: (2011)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

Medical liver biopsy: background, indications, procedure and histopathology
por: Boyd, Alexander, et al.
Publicado: (2019)

Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases?
por: Ak, Çağatay, et al.
Publicado: (2022)

The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude
por: Webb, Gwilym J., et al.
Publicado: (2021)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

Liver transplantation from a SARS-COV-2-positive donor: A road ahead or not
por: Kumar, Aman, et al.
Publicado: (2023)

Liver transplantation for late-onset presentations of acute liver failure in Wilson's disease: The UK experience over 2 decades
por: Shribman, Samuel, et al.
Publicado: (2020)

Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review
por: Paka, Prani, et al.
Publicado: (2018)

Humoral and cellular immune responses to wild-type and omicron (B.1.1.529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and patients with autoimmune hepatitis
por: Dimitriadis, Stavros, et al.
Publicado: (2022)

Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA
por: Ndugga, Nambi, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Metabolic Syndrome Frequency in Inflammatory Bowel Diseases
por: Yorulmaz, Elif, et al.
Publicado: (2011)

Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)

Outcomes of adults who received liver transplant as young children
por: Vimalesvaran, Sunitha, et al.
Publicado: (2021)

Proximity to transplant center and outcome among liver transplant patients
por: Webb, Gwilym J., et al.
Publicado: (2018)

Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?
por: Sayar, Suleyman, et al.
Publicado: (2021)

Prediction of Prognosis Acute Pancreatitis with Inflammatory Markers and Patient Characteristics Compared to the Scoring System: Real-Life Data
por: Ak, Cagatay, et al.
Publicado: (2023)

Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection
por: Feng, Jincheng, et al.
Publicado: (2019)

Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2019)

Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis
por: Rigopoulou, Eirini I, et al.
Publicado: (2007)

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022)

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
por: Deutsch-Link, Sasha, et al.
Publicado: (2022)

TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species
por: Ali, Eunus S., et al.
Publicado: (2021)

The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease
por: Yorulmaz, Elif, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_korhn7jkiqab9f0ah445gi6ajn